Angelina V.
- Country
- Italy
- Department
- UOC Neonatologia e Pediatria
Research Overview
- Phase III Evaluation of Concurrent Versus Sequential Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) in Endocrine-Responsive Early Breast Cancer
- A Multicenter Randomized Controlled Trial Comparing Short-Course Amoxicillin/Clavulanic Acid After Fever Resolution to Standard 10-Day Regimen for Febrile Urinary Tract Infections in Children
Data & Insights
Has run more than one trial at 2 of 61 partner sites.
Specializations
Breast Cancer Treatment
This investigator specializes in the treatment of endocrine-responsive early breast cancer, with particular focus on developing optimal therapeutic strategies for post-menopausal patients.
- Adjuvant Treatment Protocols
- Endocrine Therapy Integration
- Chemotherapy Timing Strategies
The investigator's work addresses the critical timing of combined therapeutic approaches in breast cancer treatment.
Endocrine Therapy Research
The investigator concentrates on the application of aromatase inhibitors in breast cancer treatment, examining their optimal implementation in combination with other therapies.
- Sequential Treatment Approaches
- Concurrent Therapy Administration
- Post-Menopausal Patient Care
Their research explores treatment timing strategies for endocrine-responsive tumors.
Disease Recurrence Prevention
The investigator focuses on developing strategies to prevent disease recurrence in early breast cancer, particularly through the optimization of treatment timing.
- Treatment Integration Methods
- Therapeutic Timing Optimization
- Long-term Outcome Studies
Their work emphasizes the importance of treatment sequence in therapeutic efficacy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.